Disruption of the RXFP1‐JAK3‐STAT3 signaling cascade by specific KD or pharmacological inhibition abolished the CTRP8‐mediated increase in cellular Cdc42 protein levels and reduced the motility of patient GBM cells. This evidence concerns the gene CDC42 and glioblastoma.